Experimental and theoretical analysis reveals excitation functions for medical isotope production at 6–80 MeV, highlighting viable pathways for cancer diagnosis and theranostics.
We discussed nuclear technologies to produce radioactive isotopes, with a focus on radionuclides used as radiopharmaceuticals in novel methods of cancer diagnosis and radionuclide therapy—theranostics. New target materials and nuclear reactions to produce these radionuclides were considered. The experimental and theoretical results of excitation functions of reactions (p, xn) studies in energy range 6–80 MeV for medium mass nuclear systems to produce radionuclides: scandium, technetium, antimony, terbium are presented. These radionuclides are promising for their use in nuclear medicine methods for diagnostics, therapy and theranostics.
No takes yet. Share an insight, caveat, or question.
Alekseev et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: